JoAnn Pinkerton, an obstetrician, criticized the FDA's black box warning labels on hormone replacement therapies, claiming they deter women from seeking beneficial treatments for menopause symptoms. She advocated for the removal of these warnings for vaginal low-dose estrogen treatments delivered locally via patches, creams, or rings. Pinkerton stated that the warnings overstate risks and lack scientific support, describing cases where patients discard medications due to fear instilled by these labels. There has been a significant shift in medical consensus regarding the safety of hormone treatments for menopause in recent years, compared to the cautious approach in the past.
"Please stop harming women," she said, emphasizing the dangers associated with the FDA's black box warning labels on hormone replacement therapies. The warnings deter women from beneficial treatments.
Pinkerton argues that such boxed warnings, which are the strongest safety labels from the FDA, are unnecessary for vaginal low-dose estrogen treatment, which is delivered locally.
Collection
[
|
...
]